ROSY METRO LIMITED acquired a 13.78% stake in M.A. Med Alliance S.A from Shenzhen Salubris Pharmaceuticals Co., Ltd. (SZSE:002294) for $45 million on June 14, 2021. ROSY METRO LIMITED completed the acquisition of a 13.78% stake in M.A. Med Alliance S.A from Shenzhen Salubris Pharmaceuticals Co., Ltd. (SZSE:002294) on June 14, 2021.